Jonathan Freeman

Jonathan Freeman is a seasoned executive with extensive experience in the life sciences sector, currently serving as a Member of the Board of Directors at Neurvati Neurosciences since August 2021. As Co-Founder and COO of Anthos Therapeutics since February 2019, Freeman has played a crucial role in the company's establishment and growth. Additionally, Freeman holds advisory positions at Blackstone Life Sciences and Clarus Funds, contributing expertise to successful healthcare investments and developments. Previous roles include Chief Business Officer at Vedanta Biosciences, Senior Vice President of Strategy & Global Portfolio Management at EMD, and key positions at Merck Serono, Baxter Healthcare, and Serono. Jonathan Freeman's academic background includes a PhD from The University of Edinburgh and multiple degrees from the University of Cambridge, including a Master of Arts in Natural Sciences.